Quotes Processa Pharmaceuticals, Inc. OTC Markets

Stocks

Market Closed - OTC Markets 15:59:06 2020-10-01 EDT			5-day change	1st Jan Change
6.100 ^USD	-38.38%		-.--%	-

08-14	Processa Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
07-29	Processa Pharmaceuticals, Inc. announced that it has received $200 million in funding from a group of investors	CI

Stock exchange

OTC Markets PCSA 6.100 $ -38.38% 71.25K $

Markets		Price	Change	Volumes
Nasdaq	PCSA	1.350USD	-4.93%	17.28K $
CBOE	PCSA	1.530USD	+4.08%	237.15 $

1 day

-38.38%

markets

Capital turnover ratio

Float rotation

Market Cap (USD)

4,759,533

Net sales (USD)

Number of employees

Sales / Employee ()

Sales / Employee (USD)

Free-Float

85.18%

Free-Float capitalization (USD)

3,378,620

RSI 9 days

RSI 14 days

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PROCESSA PHARMACEUTICALS, INC.	-38.38%	-.--%	-	-	4.76M
WUXI APPTEC CO., LTD.	-3.19%	-3.19%	+44.60%	+87.98%	74.68B
ARGENX SE	-15.86%	-16.16%	+2.68%	+50.90%	58.7B
LONZA GROUP AG	-2.39%	+0.50%	+3.41%	+31.33%	48.36B
REVOLUTION MEDICINES, INC.	-6.35%	-8.63%	+293.39%	+651.28%	43.05B
IQVIA HOLDINGS INC.	+0.30%	-0.71%	+29.05%	+30.33%	42.48B
BEONE MEDICINES AG	-3.82%	-2.41%	-0.27%	+101.36%	41.39B
CELLTRION, INC.	-2.13%	-2.18%	+7.51%	+50.31%	31.29B
BIONTECH SE	-3.35%	-4.95%	-13.38%	-17.22%	23.93B
GENMAB A/S	-5.27%	+1.86%	+12.19%	-5.34%	22.24B
Average	-8.04%	-3.20%	+42.13%	+108.99%	38.61B
Weighted average by Cap.	-5.10%	-3.89%	+45.82%	+118.20%